Clinical Trials
11
Active:0
Completed:5
Trial Phases
2 Phases
Phase 2:2
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (75.0%)Phase 2
2 (25.0%)Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion
Not Applicable
Completed
- Conditions
- Macular EdemaRetinal Vein Occlusion
- Interventions
- Drug: Intravitreal injection of ranibizumab (0.5 mg per dose)
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Barnes Retina Institute
- Target Recruit Count
- 150
- Registration Number
- NCT01428388
- Locations
- 🇺🇸
The Retina Institute, Saint Louis, Missouri, United States
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
Not Applicable
Terminated
- Conditions
- Epiretinal MembraneMacular Edema
- Interventions
- First Posted Date
- 2011-08-05
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Barnes Retina Institute
- Target Recruit Count
- 6
- Registration Number
- NCT01410201
- Locations
- 🇺🇸
St. Lukes Hospital, Chesterfield, Missouri, United States
🇺🇸St. Louis Eye Surgery and Laser Center, St. Louis, Missouri, United States
🇺🇸The Retina Institute, St. Louis, Missouri, United States
Anatomic Outcomes Following Ozurdex Injections
Completed
- Conditions
- Retinal Vein Occlusions
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Barnes Retina Institute
- Target Recruit Count
- 10
- Registration Number
- NCT01282411
- Locations
- 🇺🇸
Barnes Retina Institute, St. Louis, Missouri, United States
Use of Spectral OCT in Combination Therapy
Completed
- Conditions
- Choroidal Neovascularization
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2017-10-30
- Lead Sponsor
- Barnes Retina Institute
- Target Recruit Count
- 15
- Registration Number
- NCT01025063
Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
Phase 2
Completed
- Conditions
- Retinal Vein OcclusionPosterior Vitreous Detachment
- Interventions
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2017-10-30
- Lead Sponsor
- Barnes Retina Institute
- Target Recruit Count
- 32
- Registration Number
- NCT00831350
- Locations
- 🇺🇸
Barnes Retina Institute, Saint Louis, Missouri, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found